Collection of COVID-19 News from all over the world.
Home/America COVID-19/Corona Updates/COVID-19/US Corona/Health tech and biotech startups landed $88 billion in funding in 2022. See 16 of the hottest pitch decks founders used to raise millions from investors.
Health tech and biotech startups landed $88 billion in funding in 2022. See 16 of the hottest pitch decks founders used to raise millions from investors.
Investors poured $13.5 billion into European health startups in 2022 and $88 billion globally, per Dealroom.
Startups in digital health, pharma, and healthcare-staffing secured big rounds.
Here are 16 pitch decks that health and biotech founders used.
Startups operating in health tech and biotech enjoyed a bull run in the wake of the pandemic, with 2021 proving a record-breaking year for external investment.
The run was short-lived, however, with the Russia-Ukraine war and the broader rout on tech stocks lowering the amount of capital available to founders.
Still, a number of early- and mid-stage startups — many of which began collaborating with public health providers such as the National Health Service (NHS) — raised notable rounds. Investors focused particularly on digital health, remote monitoring, and drug discovery startups.
Startups that catered to niche demographics, or pioneered novel technology, also saw investor traction from investment firms, angel investors, and government bodies alike.
Vira Health, a startup offering personalized menopause care, bagged $12 million from Octopus Ventures, while James Corden backed wellness startup Hintsa in its $5 million round. In Germany, medical imaging startup NVision secured a $17 million government grant alongside a partnership with Siemens.
Here are 16 of the pitch decks used by health and biotech founders to attract investor funds.
Health tech
Health tech is an umbrella term encompassing everything from digital health and therapeutics, to healthcare automation and staffing platforms.
The industry saw tremendous growth in 2020 and 2021, as healthcare providers reeled from the pressures of the pandemic, staff shortages, and mounting backlogs.
Against a backdrop of cooling investor interest globally, these 11 startups raked in millions in 2022.
In the race to find a viable COVID-19 vaccine, biotechnology startups operating in medical research and drug discovery took center-stage during the pandemic, bringing in over $58 billion globally in funding in 2021.
Here are five pitch decks biotech founders used to secure funding.
No comments